A case-control study of the environmental risk factors for narcolepsy

Neuroepidemiology

Volumn 29, Issue 3-4, 2008, Pages 185-192

  Picchioni, Dante ^a,b   Hope, Chris R ^a   Harsh, John R ^a  

^a UNIVERSITY OF SOUTHERN MISSISSIPPI   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Cataplexy; Environmental risk factor; Infectious diseases; Narcolepsy; Stress

Indexed keywords

HLA DQB1 ANTIGEN;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FEMALE; FUNCTION TEST; HUMAN; INFLUENZA; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; MULTIPLE SLEEP LATENCY TEST; NARCOLEPSY; PYREXIA IDIOPATHICA; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SLEEP PATTERN;

ADULT; CALIFORNIA; CATAPLEXY; COMMUNICABLE DISEASES; DYSSOMNIAS; ENVIRONMENTAL EXPOSURE; FEMALE; FEVER OF UNKNOWN ORIGIN; HEALTH SURVEYS; HLA-DQ ANTIGENS; HUMANS; INFLUENZA, HUMAN; LIFE CHANGE EVENTS; MALE; MEMBRANE GLYCOPROTEINS; MISSISSIPPI; NARCOLEPSY; RISK FACTORS; STATISTICS AS TOPIC;

EID: 38849160021     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111581     Document Type: Article

References (42)

1. Longstreth WT Jr, Koepsell TD, Ton TG, Hendrickson AF, van Belle G: The epidemiology of narcolepsy. Sleep 2007;30:13-26.
2. Honda Y: Clinical features of narcolepsy: Japanese experiences; in Honda Y, Juji T (eds): HLA in Narcolepsy. Berlin, Springer, 1985, pp 24-57.
3. Dauvilliers Y, Montplaisir J, Molinari N, et al: Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology 2001;57:2029-2033.
4. Lin L, Faraco J, Li R, et al: The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999;98:365-376.
5. Mignot E, Guilleminault C, Dement WC, Grumet FC: Genetically determined animal models of narcolepsy, a disorder of REM sleep; in Driscoll P (ed): Genetically defined animal models of neurobehavioral dysfunction. Cambridge, Birkhauser Boston, 1992, pp 90-110.
6. Peyron C, Faraco J, Rogers W, et al: A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991-997.
7. Falconer, DS: The inheritance of liability to certain diseases, estimated from the incidence among relatives. Ann Hum Genet 1965;29:51-71.
8. Mignot E, Hayduk R, Black J, Grumet FC, Guilleminault C: HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 1997;20:1012-1020.
9. Mignot E, Kimura A, Lattermann A, et al: Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy. Tissue Antigens 1997;49:329-341.
10. Mignot E: Narcolepsy: pharmacology, pathophysiology, and genetics; in Kryger MH, Roth T, Dement WC (eds): Principles and Practices of Sleep Medicine, ed 4. Philadelphia, Elsevier Saunders, 2005, pp 761-779.
11. Matsuki K, Honda Y, Satake M, Juji T: HLA in narcolepsy in Japan; in Honda Y, Juji T (eds). HLA in Narcolepsy. Berlin, Springer, 1985, pp 58-75.
12. Mignot E: Genetic and familial aspects of narcolepsy. Neurology 1998;50:S16-S22.
13. Honda M, Honda Y, Uchida S, Miyazaki S, Tokunaga K: Monozygotic twins incompletely concordant for narcolepsy. Biol Psychiatry 2001;49:943-947.
14. Khatami R, Maret S, Werth E, et al: Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway. Lancet 2004;363:1199-1200.
15. Dauvilliers Y, Maret S, Bassetti C, et al: A monozygotic twin pair discordant for narcolepsy and CSF hypocretin-1. Neurology 2004;62:2137-2138.
16. Kaprio J, Hublin C, Partinen M, Heikkilä K, Koskenvuo M: Narcolepsy-like symptoms among adult twins. J Sleep Res 1996;5:55-60.
17. Dauvilliers Y, Carlander B, Molinari N, et al: Month of birth as a risk factor for narcolepsy. Sleep 2003;26:663-665.
18. Picchioni D, Mignot E, Harsh JR: The month-of-birth pattern in narcolepsy is moderated by cataplexy severity and may be independent of HLA-DQB1*0602. Sleep 2004;27:1471-1475.
19. Dahmen N, Tonn P: Season of birth effect in narcolepsy. Neurology 2003;61:1016-1017.
20. Billiard M, Besset A, Cadilhac J: The clinical and polygraphic development of narcolepsy; in Guilleminault C, Lugaresi E (eds): Sleep/Wake Disorders: Natural History, Epidemiology, and Long-Term Evolution. New York, Raven Press, 1983, pp 171-185.
21. Dauvilliers Y, Carlander B, Nicollet A, Billiard M: Circumstances at onset in narcolepsy (abstract). Sleep 1999;21(suppl 1):S66-S67.
22. Mercer PW, Merritt SL, Cohen FL: Environmental factors may precipitate the onset of narcolepsy (abstract). Sleep Res 1997;26:429.
23. Roth B: Narcolepsy and Hypersomnia. Basel, Karger, 1980.
24. Orellana C, Villemin E, Tafti M, et al: Life events in the year preceding the onset of narcolepsy. Sleep 1994;17:S50-S53.
25. Martyn CN, Osmond C: Parkinson's disease and the environment in early life. J Neurol Sci 1995;132:201-206.
26. Granieri E, Cassetta I: Common childhood and adolescent infections and multiple sclerosis. Neurology 1997;49(suppl 2):S42-S54.
27. Schlesselman JJ: Case-Control Studies. Design, Conduct, Analysis. New York, Oxford University Press, 1982.
28. Boiko A: Data collection guidelines for questionnaires to be used in case-control studies of multiple sclerosis. Neurology 1997;49;(suppl 2):S75-S80.
29. Holmes TH, Rahe RH: A social readjustment rating scale. J Psychosom Res 1967;11:213-218.
30. Lankford DA, Wellman JJ, O'Hara C: Post-traumatic narcolepsy in mild to moderate closed head injury. Sleep 1994;17(8 suppl):S25-S28.
31. Herman-Giddens ME, Slora EJ, Wasserman RC, et al: Secondary sexual characteristics and menses in young girls seen in office practice: a study from the pediatric research in office settings network. Pediatrics 1997;99:505-512.
32. Herman-Giddens ME, Wang L, Kock G: Secondary sexual characteristics in boys: estimates from the National Health and Nutrition Examination Survey III, 1988-1994. Arch Pediatr Adolesc Med 2001;155:1022-1028.
33. Krueger JM, Fang J: Host defense; in Kryger MH, Roth T, Dement WC (eds): Principles and Practices of Sleep Medicine, ed 4. Philadelphia, Elsevier Saunders, 2005, pp 256-265.
34. Uno H, Tarara R, Else JG, Suleman MA, Sapolsky RM: Hippocampal damage associated with prolonged and fatal stress in primates. J Neurosci 1989;9:1705-1711.
35. Woolley C, Gould E, McEwen BS: Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res 1990;531:225-231.
36. McEwen BS, Gould EA, Sakai RR: The vulnerability of the hippocampus to protective and destructive effects of glucocorticoids in relation to stress. Br J Psychiatry 1992;160(suppl 15):18-24.
37. Sapolsky RM: Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 2000;57:925-935.
38. Orr SP, Metzger LJ, Pitman RK: Psychophysiology of post-traumatic stress disorder. Psychiatr Clin North Am 2002;25:271-293.
39. Lammers GJ, Overeem S, Tijssen MA, van Dijk JG: Effects of startle and laughter in cataplectic subjects: a neurophysiological study between attacks. Clin Neurophysiol 2000;111:1276-1281.
40. Siegel JM, Nienhuis R, Gulyani S, et al: Neuronal degeneration in canine narcolepsy. J Neurosci 1999;19:248-257.
41. Fisher RP, Quigley KL: Applying cognitive theory in public health investigations: enhancing food recall with the cognitive interview; in Tanur M (ed): Questions about Questions: Inquiries into the Cognitive Basis of Surveys. New York, Russel Sage, 1992, pp 154-169.
42. Shrout PE: Scaling of stressful life events; in Dohrenwend BS, Dohrenwend BP (eds): Stressful Life Events and Their Contexts. New York, Prodist, 1981, pp 29-47.